Hosein Ameri

972 total citations
50 papers, 614 citations indexed

About

Hosein Ameri is a scholar working on Economics and Econometrics, General Health Professions and Finance. According to data from OpenAlex, Hosein Ameri has authored 50 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Economics and Econometrics, 11 papers in General Health Professions and 9 papers in Finance. Recurrent topics in Hosein Ameri's work include Health Systems, Economic Evaluations, Quality of Life (27 papers), Healthcare Systems and Reforms (9 papers) and Economic and Environmental Valuation (6 papers). Hosein Ameri is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (27 papers), Healthcare Systems and Reforms (9 papers) and Economic and Environmental Valuation (6 papers). Hosein Ameri collaborates with scholars based in Iran, Canada and Australia. Hosein Ameri's co-authors include Mahmood Yousefi, Morteza Arab‐Zozani, Hossein Safari, Azin Nahvijou, Ali Akbari Sari, Soheil Hassanipour, Thomas G. Poder, Farzan Madadizadeh, Mehdi Yaseri and Mohammad Arab and has published in prestigious journals such as SHILAP Revista de lepidopterología, Social Science & Medicine and Journal of Hepatology.

In The Last Decade

Hosein Ameri

48 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hosein Ameri Iran 14 285 140 105 70 54 50 614
Elizabeth Fowler United States 9 183 0.6× 94 0.7× 256 2.4× 34 0.5× 45 0.8× 20 783
Ailiana Santosa Sweden 17 57 0.2× 81 0.6× 171 1.6× 101 1.4× 74 1.4× 48 735
Shabnam Iezadi Iran 9 73 0.3× 144 1.0× 155 1.5× 25 0.4× 40 0.7× 29 601
Ahmad Khanijahani United States 12 69 0.2× 149 1.1× 198 1.9× 47 0.7× 61 1.1× 27 688
Aaron Baum United States 12 101 0.4× 63 0.5× 170 1.6× 37 0.5× 40 0.7× 26 632
Shaantanu Donde United Kingdom 10 54 0.2× 97 0.7× 134 1.3× 42 0.6× 16 0.3× 14 559
Md Shajedur Rahman Shawon Australia 14 83 0.3× 98 0.7× 125 1.2× 10 0.1× 33 0.6× 39 746
Dun‐Sol Go South Korea 13 52 0.2× 46 0.3× 124 1.2× 32 0.5× 22 0.4× 31 487
Guillermo Salinas‐Escudero Mexico 11 51 0.2× 50 0.4× 68 0.6× 55 0.8× 19 0.4× 52 447
Manbinder Sidhu United Kingdom 14 79 0.3× 81 0.6× 305 2.9× 17 0.2× 40 0.7× 56 642

Countries citing papers authored by Hosein Ameri

Since Specialization
Citations

This map shows the geographic impact of Hosein Ameri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hosein Ameri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hosein Ameri more than expected).

Fields of papers citing papers by Hosein Ameri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hosein Ameri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hosein Ameri. The network helps show where Hosein Ameri may publish in the future.

Co-authorship network of co-authors of Hosein Ameri

This figure shows the co-authorship network connecting the top 25 collaborators of Hosein Ameri. A scholar is included among the top collaborators of Hosein Ameri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hosein Ameri. Hosein Ameri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ameri, Hosein & Thomas G. Poder. (2024). Comparison of four approaches in eliciting health state utilities with SF-6Dv2. The European Journal of Health Economics. 26(4). 589–604. 2 indexed citations
2.
Ameri, Hosein & Thomas G. Poder. (2024). Valuing SF-6Dv2 Using a Discrete Choice Experiment in a General Population in Quebec, Canada. International Journal of Health Policy and Management. 13. 8404–8404. 7 indexed citations
3.
Poder, Thomas G. & Hosein Ameri. (2024). A novel approach for health state valuation: Multiple bounded dichotomous choice compared to the traditional standard gamble. Social Science & Medicine. 357. 117173–117173. 2 indexed citations
4.
Daroudi, Rajabali, Hojjat Zeraati, Thomas G. Poder, et al.. (2024). Valuing the SF-6Dv2 in the capital of Iran using a discrete choice experiment with duration. Quality of Life Research. 33(7). 1853–1863. 9 indexed citations
5.
Daroudi, Rajabali, Reza Goudarzi, Mehdi Yaseri, et al.. (2023). A national survey of Iranian general population to estimate a value set for the EQ-5D-5L. Quality of Life Research. 32(7). 2079–2087. 17 indexed citations
6.
Sokhanvar, Mobin, et al.. (2023). Challenges of strategic purchasing in healthcare systems of developing countries: a systematic review and meta-synthesis of qualitative studies. Journal of Public Health. 32(2). 247–258. 1 indexed citations
7.
Montazeri, Ali, et al.. (2022). Translation and validation of the Persian version of diabetic foot ulcer scaleshort form (DFS‐SF). International Wound Journal. 20(3). 822–830. 5 indexed citations
9.
Ameri, Hosein, et al.. (2022). Assessment of the properties of the EQ-5D-5L in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Expert Review of Pharmacoeconomics & Outcomes Research. 22(2). 351–364. 8 indexed citations
10.
Ameri, Hosein, et al.. (2021). Catastrophic Health Expenditure before and after of the Implementation of Health Sector Evolution Plan in Iran. INQUIRY The Journal of Health Care Organization Provision and Financing. 58. 2846643938–2846643938. 5 indexed citations
11.
Ameri, Hosein, et al.. (2021). Cost-effectiveness analysis of lung cancer screening with low-dose computed tomography in an Iranian high-risk population. Journal of Medical Screening. 28(4). 494–501. 7 indexed citations
12.
Sharifi, Mehran, et al.. (2021). Utility Values in Colorectal Cancer Patients Treated with Chemotherapy. Cancer Investigation. 40(1). 46–54. 5 indexed citations
13.
Arab‐Zozani, Morteza, et al.. (2021). Estimating Utility Values for Health States of DFU Patients Using EQ-5D-5L and cTTO. The International Journal of Lower Extremity Wounds. 21(1). 41–49. 6 indexed citations
14.
Soofi, Moslem, Morteza Arab‐Zozani, Ali Kazemi Karyani, et al.. (2021). Can Health Insurance Protect Against Catastrophic Health Expenditures in Iran? A Systematic Review and Meta‐Analysis. World Medical & Health Policy. 13(4). 695–714. 6 indexed citations
16.
Ameri, Hosein, Hossein Safari, & Thomas G. Poder. (2020). Exploring the consistency of the SF-6Dv2 in a breast cancer population. Expert Review of Pharmacoeconomics & Outcomes Research. 21(5). 1017–1024. 12 indexed citations
17.
Nosratnejad, Shirin, et al.. (2020). <p>Direct and Indirect Costs Associated with Coronary Artery (Heart) Disease in Tabriz, Iran</p>. Risk Management and Healthcare Policy. Volume 13. 969–978. 31 indexed citations
18.
Ameri, Hosein, et al.. (2020). Health-related quality of life and its associated factors in patients with type 2 diabetes mellitus. SHILAP Revista de lepidopterología. 8. 2108037314–2108037314. 30 indexed citations
20.
Yousefi, Mahmood, et al.. (2019). Assessing the performance of direct and indirect utility eliciting methods in patients with colorectal cancer: EQ-5D-5L versus C-TTO. Health Services and Outcomes Research Methodology. 19(4). 259–270. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026